Nov 30 (Reuters) - Imago BioSciences Inc:
* IMAGO BIOSCIENCES ANNOUNCES FIRST PARTICIPANT DOSED IN INVESTIGATOR-SPONSORED PHASE 1 STUDY OF BOMEDEMSTAT IN COMBINATION WITH VENETOCLAX IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA Source text for Eikon: Further company coverage: